{"id":"https://openalex.org/W2979733124","doi":"https://doi.org/10.1182/blood.v110.11.3183.3183","title":"Up-Regulation of miR-195 Expression Leads to Decreased Expression of Basic Fibroblast Growth Factor in CLL Patients Treated with DNA Methylation Inhibitors.","display_name":"Up-Regulation of miR-195 Expression Leads to Decreased Expression of Basic Fibroblast Growth Factor in CLL Patients Treated with DNA Methylation Inhibitors.","publication_year":2007,"publication_date":"2007-11-16","ids":{"openalex":"https://openalex.org/W2979733124","doi":"https://doi.org/10.1182/blood.v110.11.3183.3183","mag":"2979733124"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v110.11.3183.3183","doi":"https://doi.org/10.1182/blood.v110.11.3183.3183","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v110.11.3183.3183","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5047956491","display_name":"John D. Phillips","orcid":"https://orcid.org/0000-0003-1567-1678","observed_orcids":["https://orcid.org/0000-0003-1567-1678"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John D. Phillips","raw_affiliation_strings":["Internal Medicine, Division of Hematology, University of Utah, Salt Lake City, UT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Internal Medicine, Division of Hematology, University of Utah, Salt Lake City, UT, USA","institution_ids":["https://openalex.org/I223532165"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Ioana Pop","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Ioana Pop","raw_affiliation_strings":["Internal Medicine, Division of Hematology, University of Utah, Salt Lake City, UT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Internal Medicine, Division of Hematology, University of Utah, Salt Lake City, UT, USA","institution_ids":["https://openalex.org/I223532165"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082070319","display_name":"Kenneth M. Boucher","orcid":"https://orcid.org/0000-0003-2833-0127","observed_orcids":["https://orcid.org/0000-0003-2833-0127"]},"institutions":[{"id":"https://openalex.org/I2801159745","display_name":"Huntsman Cancer Institute","ror":"https://ror.org/03v7tx966","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801159745","https://openalex.org/I4210148268"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Ken Boucher","raw_affiliation_strings":["Cancer Center Biostatistics, Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Center Biostatistics, Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT, USA","institution_ids":["https://openalex.org/I2801159745"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103094893","display_name":"Margaret K. Yu","orcid":"https://orcid.org/0009-0003-1697-3595","observed_orcids":["https://orcid.org/0009-0003-1697-3595","https://orcid.org/0000-0002-3650-2788"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Margaret K. Yu","raw_affiliation_strings":["Internal Medicine, Division of Hematology, University of Utah, Salt Lake City, UT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Internal Medicine, Division of Hematology, University of Utah, Salt Lake City, UT, USA","institution_ids":["https://openalex.org/I223532165"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5082070319"],"corresponding_institution_ids":["https://openalex.org/I223532165","https://openalex.org/I2801159745"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.42928298,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":93},"biblio":{"volume":"110","issue":"11","first_page":"3183","last_page":"3183"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10062","display_name":"MicroRNA in disease regulation","score":0.002099999925121665,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10269","display_name":"Epigenetics and DNA Methylation","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mir-195","display_name":"miR-195","score":0.9020000100135803},{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.9139999747276306},{"id":"https://openalex.org/keywords/dna-methylation-inhibitors","display_name":"DNA methylation inhibitors","score":0.828000009059906},{"id":"https://openalex.org/keywords/azacitidine","display_name":"azacitidine","score":0.8880000114440918},{"id":"https://openalex.org/keywords/cladribine","display_name":"cladribine","score":0.9980000257492065},{"id":"https://openalex.org/keywords/promoter-hypermethylation","display_name":"promoter hypermethylation","score":0.8130000233650208},{"id":"https://openalex.org/keywords/mir-29c","display_name":"miR-29c","score":0.871999979019165},{"id":"https://openalex.org/keywords/basic-fibroblast-growth-factor","display_name":"basic fibroblast growth factor","score":0.8849999904632568},{"id":"https://openalex.org/keywords/hypomethylating-agents","display_name":"hypomethylating agents","score":0.6589999794960022},{"id":"https://openalex.org/keywords/global-dna-demethylation","display_name":"global DNA demethylation","score":0.6840000152587891},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.5130000114440918},{"id":"https://openalex.org/keywords/microrna-expression-profiling","display_name":"miRNA expression profiling","score":0.5659999847412109},{"id":"https://openalex.org/keywords/mir-17-3p","display_name":"miR-17-3p","score":0.5709999799728394},{"id":"https://openalex.org/keywords/mir-21","display_name":"miR-21","score":0.9480000138282776},{"id":"https://openalex.org/keywords/mir-126","display_name":"miR-126","score":0.7250000238418579}],"concepts":[{"id":"https://openalex.org/C2776239401","wikidata":"https://www.wikidata.org/wiki/Q416451","display_name":"Azacitidine","level":5,"score":0.8971097469329834},{"id":"https://openalex.org/C2779200787","wikidata":"https://www.wikidata.org/wiki/Q414030","display_name":"Cladribine","level":2,"score":0.8863081932067871},{"id":"https://openalex.org/C190727270","wikidata":"https://www.wikidata.org/wiki/Q874745","display_name":"DNA methylation","level":4,"score":0.7061445116996765},{"id":"https://openalex.org/C2779979206","wikidata":"https://www.wikidata.org/wiki/Q1154602","display_name":"DNA methyltransferase","level":5,"score":0.6220699548721313},{"id":"https://openalex.org/C33288867","wikidata":"https://www.wikidata.org/wiki/Q518328","display_name":"Methylation","level":3,"score":0.5207974314689636},{"id":"https://openalex.org/C91965660","wikidata":"https://www.wikidata.org/wiki/Q415875","display_name":"Methyltransferase","level":4,"score":0.4597061276435852},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4593335688114166},{"id":"https://openalex.org/C41091548","wikidata":"https://www.wikidata.org/wiki/Q26939","display_name":"Epigenetics","level":3,"score":0.44305676221847534},{"id":"https://openalex.org/C145059251","wikidata":"https://www.wikidata.org/wiki/Q310899","display_name":"microRNA","level":3,"score":0.4419994652271271},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.42872992157936096},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.42099428176879883},{"id":"https://openalex.org/C2780235182","wikidata":"https://www.wikidata.org/wiki/Q1181878","display_name":"Decitabine","level":5,"score":0.4103958010673523},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3776762783527374},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.31507784128189087},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.30542516708374023},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.1911957561969757},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.17185822129249573},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.08759984374046326},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.06165078282356262}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v110.11.3183.3183","doi":"https://doi.org/10.1182/blood.v110.11.3183.3183","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v110.11.3183.3183","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2979516477","https://openalex.org/W2138781403","https://openalex.org/W2560955616","https://openalex.org/W2154087715","https://openalex.org/W2980236019","https://openalex.org/W2036533676","https://openalex.org/W2040433434","https://openalex.org/W2605474483","https://openalex.org/W2098090450","https://openalex.org/W3082095203"],"abstract_inverted_index":{"Abstract":[0],"A":[1],"higher":[2],"than":[3],"age-expected":[4],"DNA":[5,42,72,84,405],"methylation":[6,85,406,413],"index":[7],"is":[8,303,330,392],"predictive":[9],"for":[10,157],"early":[11],"disease":[12],"progression":[13],"in":[14,36,77,93,189,203,216,227,293,318,338,371,411],"patients":[15,61,143,150,231,235,344,378,400],"with":[16,48,63,89,236,249,345,380,404],"CLL":[17,294],"(Yu":[18],"et":[19],"al.":[20],"Leukemia":[21],"Research":[22],"2006).":[23],"We":[24,382],"hypothesized":[25],"that":[26],"miRNA":[27],"expression":[28],"can":[29,45],"also":[30,276,283,323,331,369],"be":[31],"silenced":[32],"by":[33,52,128,257,355,387],"promoter":[34],"hypermethylation":[35],"CLL.":[37,346],"Thus,":[38],"methyl":[39,66],"pool":[40],"or":[41,69,91],"methyltransferase":[43,73],"inhibitors":[44],"upregulate":[46],"microRNAs":[47],"tumor":[49,278],"suppressor":[50,279],"characteristics":[51,280],"restoring":[53],"the":[54,96,99,106,132,145,152,173,185,190,205,217,228,234,253,262,339,363,389,412,416],"\u201cnormal\u201d":[55],"pattern":[56],"of":[57,60,95,109,172,178,184,242,252,261,265,309,314,326,336,360,415],"methylation.":[58],"Results":[59],"treated":[62,219,230,379],"cladribine,":[64],"a":[65,71,195,290,408],"substrate":[67],"inhibitor,":[68],"5-azacitidine,":[70],"inhibitor":[74],"were":[75,155,167,170,209],"compared":[76],"2":[78],"separate":[79],"clinical":[80],"protocols.":[81],"The":[82],"global":[83,237],"decreased":[86],"after":[87,239,374,394],"treatment":[88,375,403],"cladribine":[90,146,179,191,207,218,348],"5-azacitidine":[92,153,229],"60%":[94],"patients.":[97],"At":[98],"2006":[100],"ASH":[101],"meeting,":[102],"we":[103],"reported":[104,351],"on":[105,144,151],"consistent":[107],"upregulation":[108,241],"miR-17-3p,":[110],"miR-21,":[111],"miR-29a,":[112],"miR-29b,":[113],"miR-29c,":[114],"miR-30e,":[115],"miR-104,":[116],"miR-126,":[117],"miR-128a,":[118],"miR-130a,":[119],"miR-141,":[120],"miR-142-3p,":[121],"miR-148a,":[122],"miR-151,":[123],"miR-199a,":[124],"miR-199a*,":[125],"and":[126,148,177,246,272,322,365,373],"miR-301":[127],"real-time":[129],"PCR":[130],"using":[131],"Early":[133],"Access":[134],"Human":[135],"Panel":[136],"from":[137,141,343,377],"Applied":[138],"Biosystems.":[139],"Data":[140],"two":[142,206],"protocol":[147,154],"10":[149],"used":[156],"statistical":[158],"analyses.":[159],"Non-parametric":[160],"Wilcoxon":[161],"tests":[162],"as":[163,165,281],"well":[164],"t-tests":[166],"performed.":[168],"Comparisons":[169],"made":[171],"responders":[174],"versus":[175,180,192],"non-responders,":[176],"5-azacytidine.":[181,381],"Since":[182],"many":[183],"miRNAs":[186],"showed":[187],"differences":[188],"5-azacytidine":[193],"comparison,":[194],"second":[196],"responder":[197,220],"vs":[198],"non-responder":[199],"analysis":[200],"was":[201,212,223,244,368],"performed":[202],"which":[204,388],"subjects":[208],"removed.":[210],"MiR-195":[211,274],"statistically":[213,224],"more":[214],"upregulated":[215,226],"whereas":[221],"miR-29c":[222],"most":[225],"(p=0.02).":[232],"In":[233,399],"demethylation":[238,251],"treatment,":[240],"microRNA-195":[243],"observed":[245,370],"directly":[247],"correlated":[248],"regional":[250,409],"CpG":[254,417],"island,":[255],"confirmed":[256],"bisulfite":[258],"sequencing.":[259],"Some":[260],"predicted":[263],"targets":[264,284],"miR-195":[266,421],"include":[267],"bcl-2,":[268],"CNOT6L,":[269],"USP15,":[270],"PADAH1B1,":[271],"ESRRG.":[273],"may":[275,422],"have":[277],"it":[282],"basic":[285],"fibroblast":[286],"growth":[287,313],"factor":[288],"(FGF-2),":[289],"gene":[291],"important":[292],"angiogenesis.":[295],"There":[296],"has":[297,349],"been":[298,350],"some":[299],"evidence":[300],"suggesting":[301],"FGF-2":[302,310,329,354,361,390],"an":[304,384],"oncogene.":[305],"For":[306],"example,":[307],"overexpression":[308],"isoforms":[311],"facilitates":[312],"NIH":[315],"3T3":[316],"cells":[317,341],"low":[319],"serum":[320],"media":[321],"mediates":[324],"radioresistance":[325],"HeLa":[327],"cells.":[328],"protective":[332],"against":[333],"irradiation":[334],"activation":[335],"p53":[337],"leukemia":[340],"derived":[342],"Although":[347],"to":[352,396,402,420,424],"downregulate":[353],"inhibiting":[356],"adenosine":[357],"deaminase,":[358],"downregulation":[359],"at":[362],"transcript":[364,391],"protein":[366],"levels":[367],"before":[372],"samples":[376],"propose":[383],"alternative":[385],"mechanism":[386],"degraded":[393],"binding":[395],"excess":[397],"miR-195.":[398],"responsive":[401],"inhibitors,":[407],"decrease":[410],"status":[414],"island":[418],"5\u2032":[419],"lead":[423],"increased":[425],"expression.":[426]},"counts_by_year":[{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2019-10-18T00:00:00"}